Name: Parenteral Controlled Drug Delivery by Novel Direct Injectable Polymer de dr. Alexandre Gomes Rodrigues(Ks Omniscriptum Publishing) (en Inglés)
SKU: 62460454
Price: 85230.00 CLP
Availability: InStock
Author: Gomes Rodrigues Alexandre
ISBN: 9786202323109

portada Parenteral Controlled Drug Delivery by Novel Direct Injectable Polymer de dr. Alexandre Gomes Rodrigues(Ks Omniscriptum Publishing) (en Inglés)

Parenteral Controlled Drug Delivery by Novel Direct Injectable Polymer de dr. Alexandre Gomes Rodrigues(Ks Omniscriptum Publishing) (en Inglés)

Formato

Libro Físico

Editorial

Ks Omniscriptum Publishing

Autor

Gomes Rodrigues Alexandre

Idioma

Inglés

Encuadernación

Tapa Blanda

ISBN13

9786202323109

Parenteral Controlled Drug Delivery by Novel Direct Injectable Polymer de dr. Alexandre Gomes Rodrigues(Ks Omniscriptum Publishing) (en Inglés)

Gomes Rodrigues Alexandre (Autor) · Ks Omniscriptum Publishing · Tapa Blanda

Libro Nuevo Importado

Envío: 21 a 25 días háb.

$ 154.970$ 85.230

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 10 unidades

$ 85.230

Llega entre el 14 Oct y el 20 Oct a Santiago, Región Metropolitana. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Parenteral Controlled Drug Delivery by Novel Direct Injectable Polymer de dr. Alexandre Gomes Rodrigues(Ks Omniscriptum Publishing) (en Inglés)"

The development of drug delivery systems took place just a few decades ago, and its evolution has brought about considerable therapeutic and economic impact. The progress from preformed implants to in situ forming implants has opened new avenues of possibilities to the patients and the healthcare providers. Procedures there were once not convenient and exposed patients with possible complications can be done nowadays by the patients through a syringe in the safety of their home. The products on the market have aided the patients to combat difficult health conditions so far and will still play an important role in the future. Nevertheless, the continuation of science and technology allow us to look for further improved products. In this regard, an implant that can cause minimal damage to the patients and put them at least risk is not available yet. However, with the progress being made, this will not take a long time until it becomes a reality. The work with nanoparticles made of PGA has been covered before in our research group and others. Further study in our group has dealt with new possibilities to work with poly(glycerol adipate) as a drug conjugate.